Galectin Therapeutics CEO Joel Lewis' 2022 pay slips 17% to $974K
Galectin Therapeutics reports 2022 executive compensation
By ExecPay News
Published: October 6, 2023
Galectin Therapeutics reported fiscal year 2022 executive compensation information on October 6, 2023.
In 2022, three executives at Galectin Therapeutics received on average a compensation package of $778K, a 17% decrease compared to previous year.
Average pay of disclosed executives at Galectin Therapeutics
Joel Lewis, Chief Executive Officer, received $974K in total, which decreased by 17% compared to 2021. 54% of Lewis' compensation, or $523K, was in salary. Lewis also received $263K in bonus, $104K in option awards, as well as $85K in other compensation.
Pol F. Boudes, Chief Medical Officer, received a compensation package of $795K, which decreased by 14% compared to previous year. 60% of the compensation package, or $473K, was in salary.
Jack W. Callicutt, Chief Financial Officer, earned $567K in 2022, a 20% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on October 6, 2023.